Abstract
Breast cancer is the most prevalent type of cancer among women globally. Angiogenesis contributes significantly to breast cancer progression and dissemination. Neovascularization is concurrent with the progression and growth of breast cancer. Breast cancer cells control angiogenesis by secreting pro‐angiogenic factors like fibroblast growth factor, vascular endothelial growth factor, interleukin, transforming growth factor‐β, platelet‐derived growth factor and several others. These pro‐angiogenic factors trigger neovascularization, and thereby lead to breast cancer development and metastasis. The hypoxia‐inducible factor (HIF)‐regulated angiogenesis cascade is a crucial underlying factor in breast cancer growth and metastasis. To that end, several efforts have been made to identify druggable targets within the HIF‐angiogenesis components. However, escape pathways are a major hindrance for targeted therapies against angiogenesis. Thus, understanding the key factors that trigger breast cancer angiogenesis is critical in elucidating ways to inhibit breast cancer. The current review provides an overview of the key growth factors that trigger breast cancer angiogenesis.